Biofil Chemicals and Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 152.03 million compared to INR 136.16 million a year ago. Revenue was INR 156.08 million compared to INR 136.47 million a year ago. Net income was INR 2.49 million compared to INR 2.09 million a year ago. Basic earnings per share from continuing operations was INR 0.15 compared to INR 0.13 a year ago. Diluted earnings per share from continuing operations was INR 0.15 compared to INR 0.13 a year ago.
For the full year, sales was INR 400.35 million compared to INR 300.35 million a year ago. Revenue was INR 405.25 million compared to INR 301.32 million a year ago. Net income was INR 7.09 million compared to INR 5.6 million a year ago. Basic earnings per share from continuing operations was INR 0.44 compared to INR 0.34 a year ago. Diluted earnings per share from continuing operations was INR 0.44 compared to INR 0.34 a year ago.